Home

Pipeline

Technology

The Team

News

Contact

Welcome to BiVictriX

Established in 2016, BiVictriX Therapeutics Ltd is a North West based Biotech focused on developing novel, highly-selective, bispecific ADCs to target unmet need in blood cancer.

Through the company’s novel “Bi-Cygni Dual Targeting Technology”, BiVictriX aims to challenge the conventional ADC therapeutic approach by providing a step change in target selectivity.

BiVictriX Therapeutics Ltd. Bio Hub, Alderley Park, Alderley Edge, Cheshire SK10 4TG, UK

+44 (0) 7908 719 566   info@bivictrix.com